Arkolith/Insider Trading/ALDX/Form 4/A

Machatha Stephen

Chief Development OfficerAldeyra Therapeutics, Inc. (ALDX) · full profile →Form 4/A · filed Apr 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$36K
Net Open-Market Flow
-$36K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2024Sell(S)12K$3.16$36K253K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000950170-24-045113) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML